Global Retirement Partners’s Vivos Therapeutics VVOS Stock Holding History

Global Retirement Partners’s Portfolio VVOS Stock Details VVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23	Closed	-$71	–	4430
2025 Q3	$71	Hold	23	–	–	﹤0.01%	3808
2025 Q2	$73	Buy	+23	New	+$58	﹤0.01%	3734
2024 Q4	$99	Hold	23	–	–	﹤0.01%	3550
2024 Q3	$60	Hold	23	–	–	﹤0.01%	3434
2024 Q2	$51	Hold	23	–	–	﹤0.01%	3487
2024 Q1	$111	Hold	23	–	–	﹤0.01%	3293
2023 Q4	$165	Hold	23	–	–	﹤0.01%	3244
2023 Q3	$174	Hold	23	–	–	﹤0.01%	3129
2023 Q2	$291	Hold	23	–	–	﹤0.01%	3055
2023 Q1	$182	Hold	23	–	–	﹤0.01%	3094
2022 Q4	$229	Hold	23	–	–	﹤0.01%	2929
2022 Q3	$0	Hold	23	–	–	﹤0.01%	3010
2022 Q2	$1K	Hold	23	–	–	﹤0.01%	2597
2022 Q1	$1K	Buy	+23	New	+$1.5K	﹤0.01%	2550
2021 Q4	–	Sell	-23	Closed	-$2K	–	1787
2021 Q3	$2K	Hold	23	–	–	﹤0.01%	1857
2021 Q2	$3K	Buy	+23	New	+$3.75K	﹤0.01%	1697

Other funds holding VVOS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AWA

Acorn Wealth Advisors Grand Blanc, Michigan $343M AUM 15.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Global Retirement Partners's VVOS Position: Q4 2025 in Review

Global Retirement Partners sold out of Vivos Therapeutics (VVOS) in Q4 2025, closing a stake of 23 shares — an estimated $71 sold.

Global Retirement Partners first reported a position in VVOS in Q2 2021 and held it in 16 quarters. The position peaked at $3K in Q2 2021. 19 funds tracked by Wall St. Rank hold VVOS as of Q4 2025.

Global Retirement Partners reported no remaining Vivos Therapeutics position as of Q4 2025 after selling out during the quarter.
Global Retirement Partners sold 23 Vivos Therapeutics shares in Q4 2025, an estimated $71.
Global Retirement Partners first reported a position in Vivos Therapeutics in Q2 2021 and held it in 16 quarters.
Global Retirement Partners's Vivos Therapeutics position peaked at $3K in Q2 2021.
19 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.